Skip to content
healthcare.dev

Burrobrush Pollen

NDC 49643-362, Hymenoclea salsola, injection, from Allermed Laboratories, Inc..

Product NDC
49643-362
Status
Listed
Labeler
Allermed Laboratories, Inc.
Dosage form
INJECTION
Route
CUTANEOUS, INTRADERMAL, SUBCUTANEOUS
Product type
NON-STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA102211
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49643-362 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMBROSIA SALSOLA POLLEN.05 g/mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]

Package NDCNDC-11Package
49643-362-05496430362055 mL in 1 VIAL, MULTI-DOSE (49643-362-05)
49643-362-104964303621010 mL in 1 VIAL, MULTI-DOSE (49643-362-10)
49643-362-304964303623030 mL in 1 VIAL, MULTI-DOSE (49643-362-30)
49643-362-504964303625050 mL in 1 VIAL, MULTI-DOSE (49643-362-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49643-362 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49643-362 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49643-362. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.